Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 7/20 | 0.63 |
| ▸ | CHRM3 known ✓ | P20309 | 7/20 | 0.63 |
| ▸ | CHRM5 known ✓ | P08912 | 6/20 | 0.63 |
| ▸ | CHRM2 known ✓ | P08172 | 6/20 | 0.59 |
| ▸ | CHRM4 known ✓ | P08173 | 6/20 | 0.59 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.59 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.59 |
| ▸ | HTR1A | P08908 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | PGR | P06401 | 1/20 | 0.59 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.59 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.59 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.59 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.59 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15954 | 0.98 | CHRM5 (0.65) | CHRM1CHRM3CHRM5GALR3GAA | |
| SCHEMBL180003 | 0.98 | CHRM5 (0.65) | CHRM1CHRM3CHRM5GALR3GAA | |
| Hydrochloric Acid SCHEMBL30183040 | 0.98 | CHRM5 (0.65) | CHRM1CHRM3CHRM5GALR3GAA | |
| SCHEMBL29649178 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| SCHEMBL31575073 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| Iodide SCHEMBL723953 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| SCHEMBL28715059 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| Ammonia Solution, Strong SCHEMBL468696 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| Hydrochloric Acid SCHEMBL9492830 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA | |
| Hydrochloric Acid SCHEMBL28351837 | 0.96 | CHRM5 (0.63) | CHRM1CHRM3CHRM5GALR3GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060110-A | Polymerizable organic-inorganic hybrid flexible gel scintillator material and preparation method and application thereof | 福州大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260061062-A1 | MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM | UNIV NEBRASKA (US) | 2026-03-05 | — | — | US | claimed |
| CN-119662169-B | Negative electrode binder, negative electrode sheet and secondary battery | 深圳好电科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119529714-B | Adhesive, negative plate and battery | 深圳好电科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-20250115832-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-04-10 | — | — | US | claimed |
| CN-119768455-A | Anion exchange membrane and preparation method thereof | 东丽尖端素材株式会社 | 2025-04-04 | — | — | CN | claimed |
| CN-119662169-A | Negative electrode binder, negative electrode sheet and secondary battery | 深圳好电科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119529714-A | Adhesive, negative plate and battery | 深圳好电科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-117107528-B | Normal temperature dyeing method and dyed product obtained by same | 水木聚力接枝纺织新技术(深圳)有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-115400601-B | Anti-pollution ion exchange membrane and preparation method and application thereof | 浙江大学 | 2025-02-11 | — | — | CN | claimed |
| WO-2003030872-A2 | COMPOSITIONS HAVING A COMBINATION OF PARTICLES FOR IMMEDIATE RELEASE AND FOR CONTROLLED RELEASE | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2003-04-17 | — | — | WO | claimed |
| WO-2003024425-A1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2003-03-27 | — | — | WO | claimed |
| US-20030045637-A1 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2003-03-06 | — | — | US | claimed |
| EP-1270624-A1 | RESIN FOR PIGMENT DISPERSION | KANSAI PAINT CO., LTD. (JP) | 2003-01-02 | — | — | EP | claimed |
| WO-2002088318-A2 | LIPID-COMPRISING DRUG DELIVERY COMPLEXES AND METHODS FOR THEIR PRODUCTION | TARGETED GENETICS CORPORATION (US) | 2002-11-07 | — | — | WO | claimed |
| EP-1247821-A2 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2002-10-09 | — | — | EP | claimed |
| US-6001549-A | IMAGING ELEMENT CONTAINING ANTISTATIC AGENT | EASTMAN KODAK COMPANY (US) | 1999-12-14 | — | — | US | claimed |
| US-5618622-A | ANIONIC CARBOXYLIC ACID OR SULFONIC ACID GROUP-CONTAINING HYDROCARBON POLYMER WITH CHITOSAN POLYELECTROLYTE COATING | KIMBERLY-CLARK CORPORATION (US) | 1997-04-08 | — | — | US | claimed |
| WO-1997002077-A2 | SURFACE-MODIFIED FIBROUS MATERIAL AS A FILTRATION MEDIUM | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1997-01-23 | — | — | WO | claimed |
| US-4445521-A | ANIONIC AND CATIONIC POLYMER COMBINATION | L'OREAL (FR) | 1984-05-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260061062-A1 | MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM | CD44, ALG1, HSF1 | CHRM1 85/4885CHRM3 167/4885CHRM5 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.